Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
RBPJ
REST API REST API
Homo sapiens
RBPJ is differentially expressed in 336 experiments: 131 organism parts: liver, uterus, ... (129 more);, 205 disease states: normal, control, ... (203 more);, 118 cell types 437 cell lines 44 compound treatments and 78 other conditions.
Synonyms CBF1, SUH, RBP-J, RBPJK, IGKJRB1, RBPSUH, IGKJRB, KBF2
Orthologs Rbpsuh-rs3 (Mus musculus)   rbpjb (Danio rerio)   C1IEW7_CHICK (Gallus gallus)   SUH_CIOIN (Ciona intestinalis)   Rbpsuh (Rattus norvegicus)   Rbpj (Mus musculus)   SUH_BOVIN (Bos taurus)   Su(H) (Drosophila melanogaster)   rbpj (Xenopus laevis)   RBPJ (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding, negative regulation of transcription, DNA-dependent, protein binding, regulation of transcription, DNA-dependent, cytoplasm, transcription, DNA-dependent, nucleus, DNA recombination, nucleoplasm, nucleolus, gene expression, positive regulation of transcription of Notch receptor target, sequence-specific DNA binding transcription factor activity, recombinase activity, RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, MAML1-RBP-Jkappa- ICN1 complex
InterPro Term Beta-trefoil, IPT_TIG_rcpt, LAG1_DNA-bd
UniProt Accession D6R9K5, D6R927, D6R946, D6R9X3, D6RA45, D6RE93, D6REC2, D6REP3, D6RCM1, D6RBQ8, D6RB37, D6RAT2, D6RIZ8, D6RIV8, D6RF98, B4DY22, Q06330
Search EB-eye ENSG00000168214
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (45 experiments)

Factor Value U/D Experiments
primary culture
2
E-GEOD-2450, E-GEOD-1657
A549
2
E-GEOD-3202, E-GEOD-6013
MOLT4
2
E-MTAB-62, E-MTAB-37
MCF-7
1
2
E-GEOD-5823, E-GEOD-20081, E-GEOD-3529
K562
1
2
E-GEOD-24147, E-GEOD-96, E-MTAB-37
MDA-MB-231
1
2
E-GEOD-5823, E-MTAB-62, E-TABM-420
431 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-20677, E-TABM-34, E-GEOD-2822, E-GEOD-3998, ... (55 experiments)

Factor Value U/D Experiments
human embryonic stem cell
3
E-GEOD-18265, E-GEOD-20033, E-GEOD-18147
stromal cell
3
E-GEOD-1460, E-MEXP-2034, E-MEXP-1327
human foreskin fibroblast
2
E-GEOD-18265, E-GEOD-18147
CD8+ T cell
2
E-GEOD-6740, E-AFMX-5
monocyte
2
3
E-MEXP-583, E-GEOD-22373, E-GEOD-5099, E-GEOD-11755, E-GEOD-8286 ... (5 experiments)
endothelial cell
1
2
E-GEOD-96, E-GEOD-3998, E-GEOD-19240
112 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-1121, E-GEOD-16363, E-MTAB-62, ... (65 experiments)

Factor Value U/D Experiments
control
1
4
E-GEOD-21912, E-GEOD-16363, E-GEOD-8121, E-GEOD-20295, E-GEOD-16728 ... (5 experiments)
prostate carcinoma
3
E-MEXP-2034, E-GEOD-96, E-MTAB-37
cervical carcinoma
3
E-MTAB-37, E-MTAB-62, E-MEXP-1331
glioblastoma
2
E-GEOD-6014, E-GEOD-4290
myeloma
2
E-MTAB-62, E-MTAB-37
lung adenocarcinoma
2
E-MTAB-37, E-MTAB-62
199 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5258, E-GEOD-1417, E-GEOD-3720, E-GEOD-5824, ... (28 experiments)

Factor Value U/D Experiments
lipopolysaccharide
3
E-MEXP-1958, E-GEOD-3720, E-TABM-868
phenol
1
E-GEOD-6907
disease modifying antirheumatic drugs, non-steroidal anti-inflammatory drugs, steroids
1
E-GEOD-1919
endotoxin
1
E-GEOD-2322
unknown
1
E-GEOD-7307
ethanol
1
E-MEXP-2241
38 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
1
E-GEOD-19519
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

cd1a
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-17189, E-GEOD-6710, E-GEOD-19348, ... (11 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-GEOD-4667, E-MEXP-2283, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-22148, E-TABM-147, E-GEOD-21138, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-4025, E-MEXP-1482, E-GEOD-7578, ... (10 experiments)

Genotype
studied in E-GEOD-1045, E-GEOD-17476, E-GEOD-22593, E-TABM-868, E-GEOD-18005, ... (15 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-20540, E-GEOD-22278, ... (15 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-2069, E-GEOD-1926, E-GEOD-16363, ... (35 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-GEOD-12254, E-MEXP-561, ... (6 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-958, E-MEXP-1082, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-19703, E-GEOD-22152, E-GEOD-21750, E-GEOD-1657, E-MEXP-1403 ... (5 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, ... (7 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, E-GEOD-3697, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-MEXP-70, E-GEOD-18995

Sex
studied in E-GEOD-1643, E-GEOD-22541, E-GEOD-7307, E-GEOD-16363

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-23984, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276, E-GEOD-2748

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-22152, E-GEOD-16837, E-MEXP-973, ... (10 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-1561, E-GEOD-6532

Processing time: 0.491 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM